期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Advanced Lung Cancer—Reaching a Survival Ceiling with Chemotherapy, the Nibs, and the Mabs 被引量:1
1
作者 riccardo lencioni James Chen +1 位作者 Gordon Downie Llew Keltner 《Journal of Cancer Therapy》 2011年第2期157-160,共4页
Lung cancer is the leading cause of cancer-related death worldwide. Despite intensive research conducted during the past years, little improvement in overall survival has been achieved for patients with advanced disea... Lung cancer is the leading cause of cancer-related death worldwide. Despite intensive research conducted during the past years, little improvement in overall survival has been achieved for patients with advanced disease. Chemotherapy and radiation continue to be the mainstays of treatment for unresectable patients, and targeted agents seem to have added little improvement to overall survival while dramatically increasing costs and producing significant clinical side effects. In contrast to the immunosuppression which occurs as a result of the use of chemotherapy and pathway blockers, novel therapies are emerging which either stimulate tumor specific immune responses due to apoptotic focal tumor destruction or attack tumor-induced regulatory T-cell immunosuppression. Such new approaches should be fully explored, as they have potential to offer very different outcomes for advanced lung cancer patients. 展开更多
关键词 LUNG Cancer CHEMOTHERAPY TARGETED Therapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部